| Advances in antifungal drug development: an up-to-date mini review G Bouz, M Doležal Pharmaceuticals 14 (12), 1312, 2021 | 66 | 2021 |
| Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: an up-to-date review G Bouz, J Zitko Bioorganic chemistry 110, 104806, 2021 | 31 | 2021 |
| The zebrafish model of tuberculosis-no lungs needed G Bouz, N Al Hasawi Critical reviews in microbiology 44 (6), 779-792, 2018 | 29 | 2018 |
| Ureidopyrazine derivatives: Synthesis and biological evaluation as anti-infectives and abiotic elicitors G Bouz, M Juhás, P Niklová, O Janďourek, P Paterová, J Janoušek, ... Molecules 22 (10), 1797, 2017 | 15 | 2017 |
| Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, antimicrobial evaluation, and in vitro cytotoxicity G Bouz, L Semelková, O Janďourek, K Konečná, P Paterová, ... Molecules 24 (7), 1212, 2019 | 14 | 2019 |
| Design, synthesis, antimycobacterial evaluation, and in silico studies of 3-(phenylcarbamoyl)-pyrazine-2-carboxylic acids L Semelková, P Janošcová, C Fernandes, G Bouz, O Janďourek, ... Molecules 22 (9), 1491, 2017 | 14 | 2017 |
| Substituted N-(Pyrazin-2-yl)benzenesulfonamides; Synthesis, Anti-Infective Evaluation, Cytotoxicity, and In Silico Studies G Bouz, M Juhás, L Pausas Otero, C Paredes de la Red, O Janďourek, ... Molecules 25 (1), 138, 2019 | 10 | 2019 |
| Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence—A Systematic Review L Bouz Mkabaah, MG Davey, JC Lennon, G Bouz, N Miller, MJ Kerin International Journal of Molecular Sciences 24 (8), 7115, 2023 | 6 | 2023 |
| Synthesis, Biological Evaluation, and In Silico Modeling of N-Substituted Quinoxaline-2-Carboxamides G Bouz, S Bouz, O Janďourek, K Konečná, P Bárta, J Vinšová, M Doležal, ... Pharmaceuticals 14 (8), 768, 2021 | 5 | 2021 |
| Antimycobacterial pyridine carboxamides: From design to in vivo activity DE Nawrot, G Bouz, O Janďourek, K Konečná, P Paterová, P Bárta, ... European Journal of Medicinal Chemistry 258, 115617, 2023 | 4 | 2023 |
| Antistaphylococcal discovery pipeline; where are we now? D Nawrot, W Ambrożkiewicz-Mosler, M Doležal, G Bouz European Journal of Medicinal Chemistry, 116077, 2023 | 1 | 2023 |
| Hybridization Approach Toward Novel Antituberculars: Design, Synthesis, and Biological Evaluation of Compounds Combining Pyrazinamide and 4-Aminosalicylic Acid G Bouz, P Slechta, O Jand’ourek, K Konecná, P Paterová, P Bárta, ... ACS Infectious Diseases 9 (1), 79-96, 2022 | 1 | 2022 |
| Correction to “Hybridization Approach Toward Novel Antituberculars: Design, Synthesis, and Biological Evaluation of Compounds Combining Pyrazinamide and 4-Aminosalicylic Acid” G Bouz, P Šlechta, O Jand’ourek, K Konečná, P Paterová, P Bárta, ... ACS Infectious Diseases 9 (8), 1674-1674, 2023 | | 2023 |
| Advances in antifungal drug development: an up-to-date mini review. M Doležal, G Bouz | | 2021 |
| Derivatives of pyrazinecarboxylic acid as potential antimycobacterial active drugs. GB Bouz Univerzita Karlova, Farmaceutická fakulta v Hradci Králové, 2020 | | 2020 |
| BMS202 inhibitor G Bouz, J Zitko | | |
| Substituted N-(Pyrazin-2-yl) benzenesulfonamides G Bouz, M Juhás, LP Otero, CP de la Red, O Janďourek, K Konečná, ... | | |
